These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 676576)

  • 61. [Diagnostic assessment of normal and risk pregnancies. 1. Comparison of two radioimmunological methods for the determination of human placental lactogen (author's transl)].
    Musch K; Wolf AS; Lauritzen C
    Geburtshilfe Frauenheilkd; 1978 May; 38(5):365-70. PubMed ID: 648860
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A critical analysis of the present state of recognizing the fetal hazard in pregnancy, via hormonal determinations (author's transl)].
    Lang N; Bellmann O
    Z Geburtshilfe Perinatol; 1977 Oct; 181(5):303-20. PubMed ID: 343410
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human placental lactogen hormone in serum from pregnant women with rhesus (anti-D) isoimmunization.
    Bock JE; Gaede P; Trolle D
    Acta Obstet Gynecol Scand Suppl; 1976; 53():14-9. PubMed ID: 823788
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Concentration of placental protein 10 (PP10) in maternal serum and amniotic fluid throughout normal gestation and in pregnancy complicated by fetal growth retardation.
    Würz H; Lüben G; Bohn H; Künzig HJ; Geiger W
    Arch Gynecol; 1983; 233(3):165-74. PubMed ID: 6605116
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Monitoring the fetus.
    Duhring JL
    Obstet Gynecol Annu; 1979; 8():125-45. PubMed ID: 390449
    [No Abstract]   [Full Text] [Related]  

  • 66. [Radioimmunologic determination of estriol, HPL, and alpha fetoprotein in maternal serum and their values in pregnancies at risk (proceedings)].
    Arnold P; Rauskolb R; Jovanović V; Bleyl H
    Arch Gynakol; 1977 Jul; 224(1-4):123-4. PubMed ID: 74991
    [No Abstract]   [Full Text] [Related]  

  • 67. Antidepressants in amniotic fluid: another route of fetal exposure.
    Loughhead AM; Fisher AD; Newport DJ; Ritchie JC; Owens MJ; DeVane CL; Stowe ZN
    Am J Psychiatry; 2006 Jan; 163(1):145-7. PubMed ID: 16390902
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biochemical parameters for surveillance of high-risk pregnancies.
    Goebel R
    Horm Res; 1978; 9(6):339-64. PubMed ID: 82528
    [No Abstract]   [Full Text] [Related]  

  • 69. Human placental lactogen levels in amniotic fluid in normal and toxemic pregnancies.
    Lolis D; Kaskarelis D
    Acta Obstet Gynecol Scand; 1978; 57(4):367-9. PubMed ID: 696254
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum HPL in normal and high risk pregnancy by haemagglutination inhibition test.
    Vakharia DD; Rao SS
    Indian J Med Res; 1978 Aug; 68():272-8. PubMed ID: 721200
    [No Abstract]   [Full Text] [Related]  

  • 71. [Value of cardiac monitoring in the antenatal diagnosis of the state of the fetus in high risk pregnancies].
    Malinovskaia SIa; Klimenko PA; Baĭdaeva ZKh
    Akush Ginekol (Mosk); 1980 Aug; (8):29-31. PubMed ID: 7416391
    [No Abstract]   [Full Text] [Related]  

  • 72. [Human chorionic somatomammotropin: hCS (human placental lactogen : hPL) and estriol secretion in abnormal pregnancy (author's transl)].
    Hirai I
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1065-83. PubMed ID: 134913
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Maternal intrauterine amine alterations in the pregnant drug addict.
    Zuspan FP
    J Reprod Med; 1978 Jun; 20(6):329-32. PubMed ID: 671413
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amniotic fluid, maternal and fetal blood insulin in overweight pregnant women.
    Tzingounis V; Lolis D; Kaskarelis D
    Horm Res; 1978; 9(5):249-53. PubMed ID: 680636
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Evaluation of biochemical tests during pregnancy].
    Takagi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Sep; 36(9):1405-6. PubMed ID: 6491417
    [No Abstract]   [Full Text] [Related]  

  • 76. [Properdin levels in the amniotic fluid, maternal venous and umbilical cord blood serum in complicated pregnancy].
    Orlik-Runge T; Bartoszewicz T
    Ginekol Pol; 1984 Apr; 55(4):243-8. PubMed ID: 6500315
    [No Abstract]   [Full Text] [Related]  

  • 77. [Clinical evaluation of serum HPL levels determined by a simple and easy method (HPL HAIR Kit) in the late stage of pregnancy].
    Kaneko K; Takeishi Y; Nakamura E; Ri I; Inoue C
    Horumon To Rinsho; 1974 Aug; 22(8):995-1002. PubMed ID: 4476266
    [No Abstract]   [Full Text] [Related]  

  • 78. Total LDH activity and its fractions (L-lactate: NAD+-oxidoreductase, E.C. 1.1.1.27) in amniotic fluid and serum in high risk pregnancies.
    Soukup K; Jandová A; Bendl J; Vinsová N; Trnka V; Pezlarová J
    Acta Univ Carol Med Monogr; 1977; (78 Pt 2):105-8. PubMed ID: 615454
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum levels of human chorionic somatomammotropin (HCS) in normal and abnormal pregnancies.
    Lebech PE; Borggaard B
    Acta Endocrinol Suppl (Copenh); 1974 Jan; 182():35-43. PubMed ID: 4521558
    [No Abstract]   [Full Text] [Related]  

  • 80. [Human placental lactogen (hPL)].
    Okamura M; Mizutani S; Itakura A
    Nihon Rinsho; 1999 Dec; 57 Suppl():299-301. PubMed ID: 10778122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.